INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
03 · Corporate insiders

Form 4 filings

Officers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.

Form 4 transactions

Cluster activity · 60d

Most active filers

Companies with the most Form 4 filings
Data sources
SEC Form 45h ago
House PTR5h ago
SEC 13F5h ago
Robinhood Chain5h ago

Most active filers · 30d

  1. 01Kurtz George0B / 239S · 10 late239 trades$59.22M
  2. 02SPSaba Capital Management, L.P.68B / 23S · 14 late91 trades$30.01M
  3. 03ATAdair Kathleen Theresa52B / 0S · 52 late52 trades$18K
  4. 04AJAllaire Jeremy0B / 50S50 trades$4.26M
  5. 05Wilhelmsen Arne Alexander0B / 47S47 trades$241.96M
  6. 06SJSheena Jonathan0B / 43S43 trades$3.14M
  7. 07CFCheng Chi Fung0B / 42S42 trades$15.33M
  8. 08RJRubinstein Julie0B / 37S37 trades$6.25M
  9. 09SLSpeiser Michael L0B / 35S35 trades$14.00M
  10. 10RARothblatt Martine A0B / 33S33 trades$5.50M

Cluster activity · 60d

  1. BUYTSMTAIWAN SEMICONDUCTOR MANUFACTURING CO LTDNov 5 – Nov 631 insiders$417K
  2. SELLDRDDRDGOLD LTDOct 27 – Oct 2710 insiders$1.23M
  3. BUYMTDRMatador Resources CoNov 5 – Nov 99 insiders$642K
  4. SELLFERGFerguson Enterprises Inc. /DE/Oct 12 – Oct 167 insiders$7.38M
  5. SELLSYMSymbotic Inc.Oct 26 – Nov 27 insiders$1.98M
  6. BUYUPBDUPBOUND GROUP, INC.Nov 2 – Nov 37 insiders$1.34M
  7. SELLADUSAddus HomeCare CorpNov 6 – Nov 96 insiders$16.28M
  8. SELLARQQArqit Quantum Inc.Oct 2 – Oct 136 insiders$369K

Form 4 transactions

19,215 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
20
SA
Smith Michael AlexanderChief Legal Officer
INSMINSMED Inc
Open-market sale · 10b5-1 plan
SELL$676K
3,636 sh
Nov 3, 2025Nov 5, 2025
Page 480 of 481
← PrevNext →
traded Nov 3, 2025
+2d
SEC Form 4

Evidence

20
SM
Stetz MattiasChief Operating Officer
RSIRush Street Interactive, Inc.
Open-market sale · 10b5-1 plan
SELL$513K
30.0K sh
Nov 3, 2025Nov 5, 2025
traded Nov 3, 2025
+2dSEC Form 4

Evidence

19
BP
Burnett PatrickSee Remarks
ARQTArcutis Biotherapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$92K
3,864 sh
Nov 5, 2025Nov 5, 2025
traded Nov 5, 2025
+0dSEC Form 4

Evidence

18
MS
Mehta SatishChief Technology Officer
CHWYChewy, Inc.
Open-market sale · 10b5-1 plan
SELL$108K
3,288 sh
Nov 3, 2025Nov 5, 2025
traded Nov 3, 2025
+2dSEC Form 4

Evidence

18
SS
Singh SumitDirector, Chief Executive Officer
CHWYChewy, Inc.
Open-market sale · 10b5-1 plan
SELL$75K
2,289 sh
Nov 3, 2025Nov 5, 2025
traded Nov 3, 2025
+2dSEC Form 4

Evidence

17
OD
Owens DarrellSee remarks
SYFSynchrony Financial
Open-market sale · 10b5-1 plan
SELL$221K
2,989 sh
Nov 3, 2025Nov 5, 2025
traded Nov 3, 2025
+2dSEC Form 4

Evidence

16
SH
Siegel Ian H.Director, CHIEF EXECUTIVE OFFICER, 10% Owner
ZIPZIPRECRUITER, INC.
Open-market sale · 10b5-1 plan
SELL$39K
9,722 sh
Nov 5, 2025Nov 5, 2025
traded Nov 5, 2025
+0dSEC Form 4

Evidence

16
PM
Palasis MariaDirector
BBNXBeta Bionics, Inc.
Open-market sale · 10b5-1 plan
SELL$3,267
119 sh
Oct 31, 2025Nov 5, 2025
traded Oct 31, 2025
+5dSEC Form 4

Evidence

16
TB
Ticho BarryCHIEF MEDICAL OFFICER
STOKStoke Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$95K
3,776 sh
Nov 3, 2025Nov 5, 2025
traded Nov 3, 2025
+2dSEC Form 4

Evidence

16
LA
Lezack AdamDirector
BBNXBeta Bionics, Inc.
Open-market sale · 10b5-1 plan
SELL$1,053
38 sh
Oct 31, 2025Nov 5, 2025
traded Oct 31, 2025
+5dSEC Form 4

Evidence

16
SA
Smith Michael AlexanderChief Legal Officer
INSMINSMED Inc
Open-market sale · 10b5-1 plan
SELL$263K
1,400 sh
Nov 3, 2025Nov 5, 2025
traded Nov 3, 2025
+2dSEC Form 4

Evidence

16
SA
Smith Michael AlexanderChief Legal Officer
INSMINSMED Inc
Open-market sale · 10b5-1 plan
SELL$294K
1,572 sh
Nov 3, 2025Nov 5, 2025
traded Nov 3, 2025
+2dSEC Form 4

Evidence

15
BG
Billings William G.Chief Accounting Officer
CHWYChewy, Inc.
Open-market sale · 10b5-1 plan
SELL$37K
1,121 sh
Nov 3, 2025Nov 5, 2025
traded Nov 3, 2025
+2dSEC Form 4

Evidence

15
KM
Kidd MarkEVP, GM Data Centers & ALM
IRMIRON MOUNTAIN INC
Open-market sale · 10b5-1 plan
SELL$615K
6,000 sh
Nov 3, 2025Nov 5, 2025
traded Nov 3, 2025
+2dSEC Form 4

Evidence

15
KW
Kozarich John WDirector
LGNDLIGAND PHARMACEUTICALS INC
Open-market sale · 10b5-1 plan
SELL$24K
127 sh
Nov 3, 2025Nov 5, 2025
traded Nov 3, 2025
+2dSEC Form 4

Evidence

15
KW
Kozarich John WDirector
LGNDLIGAND PHARMACEUTICALS INC
Open-market sale · 10b5-1 plan
SELL$40K
207 sh
Nov 3, 2025Nov 5, 2025
traded Nov 3, 2025
+2dSEC Form 4

Evidence

15
KW
Kozarich John WDirector
LGNDLIGAND PHARMACEUTICALS INC
Open-market sale · 10b5-1 plan
SELL$16K
84 sh
Nov 3, 2025Nov 5, 2025
traded Nov 3, 2025
+2dSEC Form 4

Evidence

15
KW
Kozarich John WDirector
LGNDLIGAND PHARMACEUTICALS INC
Open-market sale · 10b5-1 plan
SELL$9,323
49 sh
Nov 3, 2025Nov 5, 2025
traded Nov 3, 2025
+2dSEC Form 4

Evidence

14
MS
Mehta SatishChief Technology Officer
CHWYChewy, Inc.
Open-market sale · 10b5-1 plan
SELL$152K
4,642 sh
Nov 4, 2025Nov 5, 2025
traded Nov 4, 2025
+1dSEC Form 4

Evidence

14
LP
Lee Anthony PDirector
RBLXRoblox Corp
Open-market sale · 10b5-1 plan
SELL$1.28M
12.2K sh
Nov 4, 2025Nov 5, 2025
traded Nov 4, 2025
+1dSEC Form 4

Evidence

14
LP
Lee Anthony PDirector
RBLXRoblox Corp
Open-market sale · 10b5-1 plan
SELL$1.99M
19.3K sh
Nov 4, 2025Nov 5, 2025
traded Nov 4, 2025
+1dSEC Form 4

Evidence

14
LP
Lee Anthony PDirector
RBLXRoblox Corp
Open-market sale · 10b5-1 plan
SELL$2.64M
25.3K sh
Nov 4, 2025Nov 5, 2025
traded Nov 4, 2025
+1dSEC Form 4

Evidence

13
SA
Smith Michael AlexanderChief Legal Officer
INSMINSMED Inc
Open-market sale · 10b5-1 plan
SELL$243K
1,342 sh
Nov 3, 2025Nov 5, 2025
traded Nov 3, 2025
+2dSEC Form 4

Evidence

13
KZ
Katz ZacharyGC and Head of Global Affairs
GRNDGrindr Inc.
Open-market sale · 10b5-1 plan
SELL$214K
15.6K sh
Nov 3, 2025Nov 5, 2025
traded Nov 3, 2025
+2dSEC Form 4

Evidence

13
FR
Fukushima RyanChief Operating Officer
TEMTempus AI, Inc.
Open-market sale · 10b5-1 plan
SELL$197K
2,200 sh
Nov 3, 2025Nov 5, 2025
traded Nov 3, 2025
+2dSEC Form 4

Evidence

13
FR
Fukushima RyanChief Operating Officer
TEMTempus AI, Inc.
Open-market sale · 10b5-1 plan
SELL$204K
2,300 sh
Nov 3, 2025Nov 5, 2025
traded Nov 3, 2025
+2dSEC Form 4

Evidence

12
WS
Wampler Kira SchererDirector
DOCSDoximity, Inc.
Open-market sale · 10b5-1 plan
SELL$133K
2,000 sh
Nov 3, 2025Nov 5, 2025
traded Nov 3, 2025
+2dSEC Form 4

Evidence

12
SS
Schwartz SophiaGeneral Counsel and Secretary
NXDRNextdoor Holdings, Inc.
Open-market sale · 10b5-1 plan
SELL$77K
40.0K sh
Nov 3, 2025Nov 5, 2025
traded Nov 3, 2025
+2dSEC Form 4

Evidence

11
KJ
Kramer Douglas JamesChief Legal Officer
NETCloudflare, Inc.
Open-market sale · 10b5-1 plan
SELL$297K
1,163 sh
Nov 3, 2025Nov 5, 2025
traded Nov 3, 2025
+2dSEC Form 4

Evidence

11
WC
Wren ChrisVP of Operations
PLNHPlanet 13 Holdings Inc.
Open-market sale · 10b5-1 plan
SELL$6,063
30.0K sh
Oct 31, 2025Nov 5, 2025
traded Oct 31, 2025
+5dSEC Form 4

Evidence

11
Dines DanielDirector, CEO and Chairman, 10% Owner
PATHUiPath, Inc.
Open-market sale · 10b5-1 plan
SELL$678K
45.0K sh
Nov 5, 2025Nov 5, 2025
traded Nov 5, 2025
+0dSEC Form 4

Evidence

11
SH
Siegel Ian H.Director, CHIEF EXECUTIVE OFFICER, 10% Owner
ZIPZIPRECRUITER, INC.
Open-market sale · 10b5-1 plan
SELL$40K
9,722 sh
Nov 4, 2025Nov 5, 2025
traded Nov 4, 2025
+1dSEC Form 4

Evidence

11
HP
Hartung Michael PChief Commercial Officer
FLEXFLEX LTD.
Open-market sale · 10b5-1 plan
SELL$279K
4,442 sh
Nov 4, 2025Nov 5, 2025
traded Nov 4, 2025
+1dSEC Form 4

Evidence

11
HP
Hartung Michael PChief Commercial Officer
FLEXFLEX LTD.
Open-market sale · 10b5-1 plan
SELL$655K
10.6K sh
Nov 4, 2025Nov 5, 2025
traded Nov 4, 2025
+1dSEC Form 4

Evidence

10
BM
Barrett David MichaelDirector, Chief Executive Officer
EXFYExpensify, Inc.
Open-market sale · 10b5-1 plan
SELL$48K
30.0K sh
Nov 3, 2025Nov 5, 2025
traded Nov 3, 2025
+2dSEC Form 4

Evidence

10
SN
Sieffert Kristen NPresident
FOAFinance of America Companies Inc.
Open-market sale · 10b5-1 plan
SELL$16K
750 sh
Nov 3, 2025Nov 5, 2025
traded Nov 3, 2025
+2dSEC Form 4

Evidence

10
FR
Fukushima RyanChief Operating Officer
TEMTempus AI, Inc.
Open-market sale · 10b5-1 plan
SELL$44K
500 sh
Nov 3, 2025Nov 5, 2025
traded Nov 3, 2025
+2dSEC Form 4

Evidence

10
VD
Vidal DanielDirector
EXFYExpensify, Inc.
Open-market sale · 10b5-1 plan
SELL$14K
9,000 sh
Nov 3, 2025Nov 5, 2025
traded Nov 3, 2025
+2dSEC Form 4

Evidence

9
TB
Ticho BarryCHIEF MEDICAL OFFICER
STOKStoke Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$38K
1,455 sh
Nov 3, 2025Nov 5, 2025
traded Nov 3, 2025
+2dSEC Form 4

Evidence

9
TB
Ticho BarryCHIEF MEDICAL OFFICER
STOKStoke Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$17K
600 sh
Nov 3, 2025Nov 5, 2025
traded Nov 3, 2025
+2dSEC Form 4

Evidence